BrightSpring Health Services announced a secondary offering of 15 million shares by existing stockholders including a KKR affiliate, with a concurrent share repurchase of up to $60 million. The company receives no proceeds from the offering.
BrightSpring Health Services announced a secondary offering of 15 million shares by existing stockholders including a KKR affiliate, with a concurrent share repurchase of up to $60 million. The company receives no proceeds from the offering.

BrightSpring Health Services announced a secondary offering of 15 million shares by existing holders, with a concurrent share repurchase of as much as $60 million.
The selling stockholders include an affiliate of Kohlberg Kravis Roberts & Co. and certain members of management, according to a statement Wednesday. BrightSpring is not selling any shares and will receive no proceeds from the offering. Goldman Sachs & Co. is acting as sole book-running manager for the proposed offering, which will be made under an effective Form S-3 shelf registration filed with the SEC in June 2025.
The company authorized the purchase of up to the lesser of 10 percent of shares sold in the offering or $60 million from the underwriter at the same price paid to selling stockholders. The underwriter will not receive fees on repurchased shares. The buyback is conditioned on the offering's closing but the offering does not depend on the repurchase, the company said.
BTSG shares closed at $59.15 on Wednesday, 4.77 percent below their 52-week high of $62.11 and more than three times their 52-week low of $19.01, which was set in the past year. The stock traded down 1.07 percent during the session, alongside weakness in health-services peers including Waystar Holding Corp., which fell 2.21 percent, and Privia Health Group Inc., down 1.47 percent. Trading volume of 1.63 million shares was below the 20-day average of 2.38 million, suggesting a measured reaction before the offering's pricing.
The transaction follows a similar structure from March, when BrightSpring announced a 20 million-share secondary with the same repurchase cap of 10 percent or $60 million. That deal produced an average 24-hour decline of 2.24 percent. The repeat pattern suggests existing shareholders, including KKR, are seeking liquidity after the stock's roughly 200 percent rally from its 52-week low of $19.01. The 15 million-share offering is smaller than the March deal, which may reduce the overhang effect on the stock. BrightSpring, a provider of home and community-based health services for complex populations, operates across all 50 states.
The secondary offering gives KKR, which took BrightSpring private in 2019 before the company's 2024 IPO, a path to monetize part of its stake. Investors will watch the offering's pricing and the extent of the company's actual repurchase execution for signals on near-term support. The company's next quarterly earnings report will provide an update on leverage and cash flow metrics that determine its capacity for further buybacks. If the full $60 million repurchase is executed, it would offset roughly 10 percent of the shares sold in the offering, providing a partial buffer against the increased float. The offering is expected to close within days of pricing.
This article is for informational purposes only and does not constitute investment advice.